(1) Tucci M, Benghuzzi H: Structural changes in the kidney associated with ovariectomy and diosgenin replacement therapy in adult female rats. Biomed Sci Instrum. 2003;39:341-6.
(2) Benghuzzi H, Tucci M, Eckie R, Hughes J.:The effects of sustained delivery of diosgenin on the adrenal gland of female rats. Biomed Sci Instrum. 2003;39:335-40.
(3) Higdon K, Scott A, Tucci M, Benghuzzi H, Tsao A, Puckett A, Cason Z, Hughes J: The use of estrogen, DHEA, and diosgenin in a sustained delivery setting as a novel treatment approach for osteoporosis in the ovariectomized adult rat model. Biomed Sci Instrum. 2001;37:281-6.
(4) Yen ML, Su JL, Chien CL, Tseng KW, Yang CY, Chen WF, Chang CC, Kuo ML: Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts. Mol Pharmacol. 2005 Oct;68(4):1061-73. Epub 2005 Jul 5.
(5) Jan-TongRong; Wey-ShiawPyng; Kuan-ChioChin; Liao-MeiHsiu; Wu-HsinYin: Diosgenin, a steroidal sapogenin, enhances antigen-specific IgG2a and interferon- gamma expression in ovalbumin-sensitized BALB/c mice. Planta-Medica. 2007; 73(5): 421-426
(6) Wang LJ, Wang Y, Chen SW, Ma JS, Fu Q, Wang BX: The antitumor activity of Diosgenin in vivo and in vitro: Zhongguo Zhong Yao Za Zhi. 2002 Oct;27(10):777-9
(7) Shishodia,-S; Aggarwal,-B-B: Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I kappa B kinase activation and NF- kappa B-regulated gene expression. Oncogene-. 2006; 25(10): 1463-1473
(8) Leger,-D-Y; Liagre,-B; Corbiere,-C; Cook-Moreau,-J; Beneytout,-J-L: Diosgenin induces cell cycle arrest and apoptosis in HEL cells with increase in intracellular calcium level, activation of cPLA2 and COX-2 overexpression. Int-J-Oncol. 2004 Sep; 25(3): 555-62
(9) Wang,-Y-J; Liu,-Y-C; Chang,-H-D; Wu,-S-N : Diosgenin, a plant-derived sapogenin, stimulates Ca2+-activated K+ current in human cortical HCN-1A neuronal cells. Planta-Med. 2006 Apr; 72(5): 430-6
(10) Juarez Oropeza, M A : Diaz Zagoya, J C : Rabinowitz, J L: In vivo and in vitro studies of hypocholesterolemic effects of diosgenin in rats. Int-J-Biochem. 1987; 19(8): 679-83
(11) Ma,-H-Y; Zhao,-Z-T; Wang,-L-J; Wang,-Y; Zhou,-Q-L; Wang,-B-X: Comparative study on anti-hypercholesterolemia activity of diosgenin and total saponin of Dioscorea panthaica. Zhongguo-Zhong-Yao-Za-Zhi. 2002 Jul; 27(7): 528-31
(12) Accatino, L : Pizarro, M : Solis, N : Koenig, C S: Effects of diosgenin, a plant-derived steroid, on bile secretion and hepatocellular cholestasis induced by estrogens in the rat. Hepatology. 1998 Jul; 28(1): 129-40
(13) Son IS, Kim JH, Sohn HY, Son KH, Kim JS, Kwon CS: Antioxidative and hypolipidemic effects of diosgenin, a steroidal saponin of yam (Dioscorea spp.), on high-cholesterol fed rats. Biosci Biotechnol Biochem. 2007 Dec;71(12):3063-71
(14) Han, N., Xu, J., Xu, F., Liu, Z., & Yin, J.: The in vivo effects of a fraction from Dioscorea spongiosa on glucocorticoid-induced osteoporosis. Journal of Ethnopharmacology, 2016; 185, 53-59.
References Interactions:
(1) Stargrove Mitchell Bebel, Treasure Jonathan, McKee Dwight L.: Herb, Nutrient, and Drug Interactions: Clinical Implications and Therapeutic Strategies. 2008
(2) Gröber Uwe: Mikronährstoffe. Metabolic Tuning – Prävention – Therapie. 3. Auflage, 2011
(3) Gröber Uwe: Arzneimittel und Mikronährstoffe. Medikationsorientierte Supplementierung. 2. Auflage, 2012
|